Lisdexamfetamine for methamphetamine withdrawal: clinical trial A clinical trial in Australia to test lisdexamfetamine as a treatment for methamphetamine withdrawal (the OLAM trial)
Ketamine-assisted psychotherapy for methamphetamine use disorder (KAPPA) An open-label, safety and feasibility pilot study of ketamine-assisted psychotherapy for methamphetamine use disorder
Measuring meaningful outcomes in trials of medications for methamphetamine use disorder Findings from a systematic review, and lived and living experience perspectives
Community-led approaches to drug monitoring and early warning: Lessons from the around the world NCCRED and AIVL hosted a discussion on how lived and living experience perspectives can be meaningfully embedded in drug monitoring systems.
Next steps in prescription stimulants as a treatment for methamphetamine use disorder A presentation on the findings of the LiMA trial and this study could mean for clients and the treatment of methamphetamine use disorder
Medication-assisted psychotherapy for methamphetamine use disorder Examining emerging research into psilocybin- and ketamine-assisted psychotherapy.
